Willenborg DO, Sjollema P, Danta G. The fate of neonatally injected effector cells of allergic encephalomyelitis.
Scand J Immunol 1986;
23:75-80. [PMID:
3486457 DOI:
10.1111/j.1365-3083.1986.tb01944.x]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Lymphocytes from rats sensitized with basic protein (BP) plus complete Freund's adjuvant (CFA), which produce allergic encephalomyelitis when transferred to adult recipients, fail to induce disease when transferred to 3- to 5-day-old neonatal rats. The transferred cells do, however persist in the recipients and can be revealed by actively challenging with BP-CFA later in adult life. Challenge leads to a significantly earlier onset of disease than is seen in control animals. We report here that the cells are long lived and persist in the recipients for at least 9 months. The cells can be demonstrated in the spleen and lymph nodes of recipient animals and can be activated by homologous and cross-reacting encephalitogenic antigenic preparations but not by antigen in nonencephalitogenic forms. These neonatal recipients, which carry autoimmune effector cells asymptomatically for prolonged periods, may provide a useful model for advancing our understanding of immunoregulatory events in this experimental demyelinating disease as well as the human demyelinating disease multiple sclerosis.
Collapse